SKYA vs MCK vs STVN Stock Comparison

SkyAI, Mckesson and Stevanato Group S.p.A Prices as of Oct 29, 2026 Peers: Industry group
1 more company in this comparison (BDX) Create a free account to keep reading and compare up to 10 companies.
SKYA SkyAI, Inc.
$2.93 +60.1% 1M -40.9% 1Y
Market cap
$214.84M
P/E
–
Revenue (TTM)
$194.22K
Div. yield
–
Medical Supplies Healthcare
2 wins
MCK Mckesson Corp
$981.33 +13.5% 1M +21.5% 1Y
Market cap
$118.07B
P/E
25.7x
Revenue (TTM)
$410.98B
Div. yield
0.00%
Drug Distribution Healthcare
7 wins
STVN Stevanato Group S.p.A.
$20.29 -4.3% 1M -21.4% 1Y
Market cap
$5.30B
P/E
33.7x
Revenue (TTM)
$1.43B
Div. yield
–
Medical Supplies Healthcare
2 wins

Head to Head

11 decided of 12

Mckesson leads on 7 of the 12 questions below (Mckesson 7, SkyAI 2, Stevanato Group S.p.A 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionSKYAMCKSTVNLeader
Larger companyMarket capitalisation $214.84M $118.07B $5.30B MCK
Cheaper on earningsLower P/E, profitable companies only -0.7x 25.7x 33.7x MCK
Cheaper on forward earningsLower price / next fiscal year consensus EPS 0.0x 20.8x 30.7x SKYA
Faster revenue growthRevenue growth, trailing twelve months +108.9% +8.8% +14.8% SKYA
More profitableNet margin, trailing twelve months -158,431.4% 1.1% 11.0% STVN
Better return on capitalReturn on invested capital — 107.9% 7.2% MCK
Less leveragedLower net debt / EBITDA — 0.6x 1.2x MCK
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -40.9% +21.5% -21.4% MCK
Better 5-year returnAnnualised price return, 5 years — +36.4%/yr -4.6%/yr MCK
Less volatileAnnualised volatility, 1 year 105.8% 30.8% 45.8% MCK
Higher overall scoreMean of the five percentile scores vs peers 26/100 59/100 67/100 STVN

Percentile Scorecard

SKYAMCKSTVN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisSKYAMCKSTVN
Valuation 2 #222 of 227 54 #12 of 25 80 #46 of 227
Growth 7 #203 of 218 65 #9 of 24 58 #92 of 218
Profitability 1 #200 of 202 70 #8 of 24 83 #36 of 202
Financial Health 94 #14 of 233 48 #14 of 26 72 #66 of 233
Shareholder Returns – 60 #7 of 16 41 #77 of 130
Overall 26 59 67
  • SKYA ranked among 247 companies in Medical Devices and Diagnostics
  • MCK ranked among 27 companies in Healthcare Payers and Distributors
  • STVN ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodSKYAMCKSTVNSPY
1 month +60.1%+13.5%-4.3% +0.7%
3 months +118.7%+13.3%+0.4% +3.7%
6 months +64.1%+20.4%+19.4% +7.1%
Year to date +44.3%+19.6%+0.8% +12.8%
1 year -40.9%+21.5%-21.4% +11.9%
3 years -99.9%+118.3%-25.8% +85.2%
3 years, per year -90.2%+29.8%-9.5% +22.8%
5 years —+372.1%-21.0% +67.6%
5 years, per year —+36.4%-4.6% +10.9%
10 years —+690.7%— +262.0%
10 years, per year —+23.0%— +13.7%

Risk

MeasureSKYAMCKSTVNSPY
Volatility, 1Y 105.8%30.8%45.8% 12.7%
Downside volatility, 1Y 104.6%27.4%44.7% 12.6%
Beta vs S&P 500, 1Y 2.59-0.281.10 1.00
Return / volatility, 1Y -0.390.70-0.47 0.94
Max drawdown, 5Y -100.0%-27.2%-62.2% -25.4%
From 52-week high -40.9%-4.7%-21.4% -1.2%
52-week high $4.96$1,030.18$25.80 $779.14
52-week low $0.95$725.17$13.43 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleSKYAMCKSTVN
P/E now vs peer median -0.7xmedian 28.7x 25.4xmedian 24.3x 35.3xmedian 28.7x
P/S now vs peer median 1,088xmedian 3.0x 0.3xmedian 0.3x 4.3xmedian 3.0x
EV/EBITDA now vs peer median —median 17.8x 16.4xmedian 12.9x 19.0xmedian 17.8x
P/FCF now vs peer median —median 26.4x 17.8xmedian 16.4x 10.4xmedian 26.4x
P/B now vs peer median 1.3xmedian 2.4x -27.0xmedian 2.5x 3.5xmedian 2.4x
PEG now vs peer median 0.01median 0.99 2.12median 1.36 -131.55median 0.99

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsSKYAMCKSTVN
Revenue $194.22K $410.98B $1.43B
Gross profit $321.93K $14.96B $416.82M
Operating income -$289.52M $6.50B $233.97M
Net income -$307.71M $5.30B $157.06M
Free cash flow – $6.42B $592.88M
R&D $399.91K – $29.75M
EPS (diluted) $-4.27 $38.52 $0.58
Cash & equivalents $12.07M $5.16B $89.82M
Total debt – $9.73B $2.11B
Shares (diluted) 72.09M 119.20M 272.96M
Enterprise value $173.54M $101.97B $4.74B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricSKYAMCKSTVN
P/E -0.7x 25.4x 35.3x
P/FCF – 17.8x 10.4x
P/Operating cash flow – 16.7x 21.2x
P/S 1,088x 0.3x 4.3x
P/B 1.3x -27.0x 3.5x
P/Tangible book 16.3x -13.9x 3.6x
EV/EBITDA – 16.4x 19.0x
EV/EBIT -0.7x 18.3x 28.0x
EV/Revenue 1,025x 0.3x 4.6x
EV/FCF – 18.5x 11.0x
EV/Operating cash flow – 17.4x 22.6x
PEG (3Y EPS CAGR) 0.01 2.12 -131.55

Growth

14 metrics
MetricSKYAMCKSTVN
Revenue growth (1Y) 108.9% 8.8% 14.8%
Revenue CAGR (3Y) 23.8% 13.1% 9.8%
Gross profit growth (1Y) – 11.2% 19.4%
Gross profit CAGR (3Y) – 6.6% 6.2%
Operating income growth (1Y) -5,525% 46.6% 17.2%
Operating income CAGR (3Y) -212.8% 13.5% 4.5%
Net income growth (1Y) -42,440% 58.1% 7.5%
Net income CAGR (3Y) -238.0% 10.7% 0.8%
EPS growth (1Y) -487.2% 52.8% 6.7%
EPS CAGR (3Y) -84.2% 12.0% -0.3%
Operating cash flow growth (1Y) – 4.7% 30.4%
Operating cash flow CAGR (3Y) – 10.7% 32.9%
Free cash flow growth (1Y) – 6.8% 17.2%
Free cash flow CAGR (3Y) – 11.3% 8.0%

Profitability

14 metrics
MetricSKYAMCKSTVN
Gross margin 165.8% 3.6% 29.2%
EBITDA margin – 1.8% 24.1%
Operating margin -149,065% 1.6% 16.4%
Pretax margin -151,352% 1.6% 15.7%
Net margin -158,431% 1.1% 11.0%
FCF margin – 1.6% 41.5%
Operating cash flow margin – 1.7% 20.3%
Return on equity -140.2% – 8.9%
Return on assets -137.6% 6.2% 5.3%
Return on invested capital – 107.9% 7.2%
Return on capital employed -136.7% 43.4% –
Asset turnover 0.0x 4.8x 0.5x
Cash conversion (OCF / net income) – 1.3x 1.8x
Stock comp / revenue 48,037% – –

Financial Health

11 metrics
MetricSKYAMCKSTVN
Debt / assets – 11.0% 17.0%
Debt / equity – -2.3x 0.3x
Net debt / EBITDA – 0.6x 1.2x
Debt / FCF – 1.5x 0.9x
Liabilities / assets 1.9% 104.8% 40.8%
Equity / assets 98.1% -4.8% 59.2%
Interest coverage – 23.6x 14.9x
Current ratio 5.3x 0.9x –
Quick ratio 4.4x 0.5x –
Cash ratio 4.2x 0.1x –
Altman Z-score 31.69 5.90 –

Shareholder Returns

7 metrics
MetricSKYAMCKSTVN
Dividend yield – 0.3% 0.2%
Net buyback yield – 5.8% –
Shareholder yield – 6.1% 0.2%
Payout ratio (earnings) – 7.4% –
Payout ratio (FCF) – 6.1% –
Dividend growth (1Y) – 11.3% –
Dividend CAGR (3Y) – 10.0% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusSKYAMCKSTVN
Forward P/E 0.0xFY2026 20.8xFY2026 30.7xFY2026
EPS, next fiscal year $2,362.06FY2026 $47.15FY2026 $0.66FY2026
EPS growth, next FY – +20.6%FY2026 +4.8%FY2026
EPS growth, the year after – +11.0% +15.2%
Revenue, next fiscal year $70.01MFY2026 $444.47BFY2026 $1.46BFY2026
Revenue growth, next FY +34,200.1%FY2026 +10.2%FY2026 +5.1%FY2026
Revenue growth, the year after +17.5% +1.5% +10.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersSKYAMCKSTVN
Held by institutions – 89.1% 16.4%
Institutions holding – 2,011 126
Change in shares held, QoQ – -0.7% +0.4%
Institutions buying – 883 61
Institutions selling – 791 52
Buyers to sellers – 1.12 1.17

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

SKYAMCKSTVN
SKYA 1.00 -0.11 0.13
MCK -0.11 1.00 -0.05
STVN 0.13 -0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, SKYA, MCK and STVN?

Mckesson (MCK) is the largest by market capitalisation: SkyAI (SKYA) $214.84M, Mckesson (MCK) $118.07B, Stevanato Group S.p.A (STVN) $5.30B.

Which stock is cheaper, SKYA, MCK and STVN?

Mckesson (MCK) trades on the lowest price-to-earnings ratio (SkyAI (SKYA) -0.7x, Mckesson (MCK) 25.7x, Stevanato Group S.p.A (STVN) 33.7x). On next year's consensus earnings, SkyAI (SKYA) is cheapest (SkyAI (SKYA) 0.0x, Mckesson (MCK) 20.8x, Stevanato Group S.p.A (STVN) 30.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: SkyAI (SKYA) +108.9%, Mckesson (MCK) +8.8%, Stevanato Group S.p.A (STVN) +14.8%.

Which company is more profitable?

Stevanato Group S.p.A (STVN) has the highest net margin (SkyAI (SKYA) -158,431.4%, Mckesson (MCK) 1.1%, Stevanato Group S.p.A (STVN) 11.0%). On return on invested capital, Mckesson (MCK) leads (Mckesson (MCK) 107.9%, Stevanato Group S.p.A (STVN) 7.2%).

Which stock has performed better?

Over the past year Mckesson (MCK) returned the most: SkyAI (SKYA) -40.9%, Mckesson (MCK) +21.5%, Stevanato Group S.p.A (STVN) -21.4%. Over five years, Mckesson (MCK) compounded fastest (Mckesson (MCK) +36.4%/yr, Stevanato Group S.p.A (STVN) -4.6%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: SkyAI (SKYA) 0.00%, Mckesson (MCK) 0.00%, Stevanato Group S.p.A (STVN) 0.00%. SkyAI (SKYA) and Stevanato Group S.p.A (STVN) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Mckesson (MCK) has been the steadiest (SkyAI (SKYA) 105.8%, Mckesson (MCK) 30.8%, Stevanato Group S.p.A (STVN) 45.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, SKYA, MCK and STVN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Mckesson (MCK) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.